Natalizumab Has Benefits on Disability
Natalizumab Has Benefits on Disability and Quality of Life in
Patients With Relapsing MS: Presented at EFNS
GLASGOW, UK
Monotherapy with the alpha4 integrin antagonist natalizumab results in significant
improvements in scores on health-related quality of life (QoL)
questionnaires in patients with relapsing-remitting multiple
sclerosis (MS), according to results of a substudy from a
multicentre, randomised, double-blind, placebo-controlled, phase 3
clinical trial. The findings were presented here on September 5[th at
the 10th Congress of the European Federation of… read more »
